An exercise-driven course on Advanced Python Programming that was battle-tested several hundred times on the corporate-training circuit for more than a decade. Written by David Beazley, author of the ...

HEBER CITY, Utah — An artificial intelligence that writes police reports had some explaining to do earlier this month after it claimed a Heber City officer had shape-shifted into a frog. However, the ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

The Trump administration said in court filings Monday that it would use contingency funds to provide partial SNAP benefits in November after a judge on Friday ordered the Department of Agriculture to ...

AI-powered bug hunting has changed the calculus of what makes for an effective bounty program by accelerating vulnerability discovery — and subjecting code maintainers to ballooning volumes of AI flaw ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

With the prevalence of microcontrollers (MCUs) as processing units in safety-related systems (SRS) comes the need for diagnostic measures that will ensure safe operation. IEC 61508-2 specifies ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in ...

A pilot program in six states will use a tactic employed by private insurers that has been heavily criticized for delaying and denying medical care. By Reed Abelson and Teddy Rosenbluth Like millions ...